Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImmCoVA: Anakinra vs Tocilizumab in Severe COVID-19
NCT04412291Phase 2Unknown
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Modality
- Antibody Conjugates, Cytokines & Interferons, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra, tocilizumab in coronavirus disease 2019 (COVID-19), sponsored by Karolinska University Hospital. Status: unknown.
02
Drugs
anakinratocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04412291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412291.